GeneCentric Data Suggest Fragmentomics Could Expand Liquid Biopsy Beyond Mutation Testing
Presentations at AACR 2026 will showcase fragmentomics-based technology for detecting therapeutic markers and providing prognostic insight.
Latest Articles
Editor's Top Picks
FDA Clears At-Home Cervical Cancer Screening Tool
The clearance of the Onclarity HPV Self-Collection Kit and approval of the BD Onclarity HPV Assay aim to reduce barriers for unscreened populations.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Alternative Blood Test More Effective for Guiding Heart Disease Treatment
Research indicates that apolipoprotein B testing outperforms standard LDL cholesterol tests in predicting risk and guiding therapy.
Equipment & Supply Spotlight
SPT Labtech and EMBL GeneCore Partner to Advance Automated Genomics Workflows
The collaboration focuses on implementing a liquid handling platform to streamline end-to-end laboratory processes and protocol development.
News, Know-How & Standards
Disease Detection & Understanding
Ataraxis AI Launches Test to Predict Response to Neoadjuvant Therapy in Breast Cancer
The tool uses digitized pathology slides to estimate how patients will respond to therapy before surgery.
